Categories

Webinar: Use of REDCap for the improvement of health care processes (in Spanish)

The Unit of Medicines and Health Technologies of PAHO / WHO is pleased to invite you to:

Webinar: Use of REDCap for the improvement of health care processes (in Spanish)

Friday, February 16, 2018, 10:00 a.m. of Washington DC, United States

REDCap is a web software created by Paul Harris and colleagues at Vanderbilt University and designed for data management in Translational Research. With more than 10 years of development it offers a large number of features that make it attractive for researchers (multi-projects, security, surveys, randomization, branches, blind, automatic emails, access groups, user profiles, among many others). All this has led REDCap to be adopted by more than 2700 institutions, reaching almost 700,000 users in 117 countries, and has been cited in more than 4700 publications. Although the initial intention was to develop a software for Research, the use of this tool for management and operation is being increasingly validated worldwide. This presentation aims to convey the success stories of the use of REDCap for both clinical and administrative management of health care.

Cristóbal Carvajal is a surgeon, graduated from “Universidad del Desarrollo”, Santiago Chile. 5 years ago, she works in the Biomedical Informatics Department at “Clínica Alemana de Santiago”, and since 2015 she is in charge of the Clinical Data Unit. The development of its activity has been based on innovation and creative solution of problems through the use of information, so it has specialized in the modeling and data capture in different scenarios. He recently completed a stay at Quality & Improvement at the Children’s Hospital of Philadelphia, USA, which has allowed him to complement his vision of data analysis with quality aspects. Dr. Carvajal is an advanced user of the REDCap software and a pioneer in the use of this tool for purposes other than research, which has allowed him to capture information and optimize various processes in multiple scenarios. He has presented his experience in various congresses in Chile, Argentina and USA. He is an active participant in the REDCap community and a member of the Spanish-speaking group. In addition, from 2013 to the present, he works as a clinician in an Emergency Service of the “Mutual de Seguridad” (which covers accidents at work and occupational diseases).

Diego Macías Saint-Gerons has a degree in pharmacy from the University of Salamanca, a Master’s Degree in Quantitative Methods of Research in Epidemiology from the Autonomous University of Madrid and a PhD in Health Sciences from the Complutense University of Madrid. He is the author of numerous scientific articles on the use of drugs and their effects. He has worked at the University of Valladolid, the Spanish Agency for Medicines and Health Products (AEMPS), and as an expert of the European Medicines Agency (EMA). He is currently working as an international consultant (IPC) in the Medicines and Health Technologies Unit of PAHO / WHO.

Access will be provided through: https://paho.webex.com/paho/onstage/g.php?MTID=e11f25011f597fc2e8ea93b378557adc4

Additionally, it can be accessed by telephone through the United States line: + 1-415-655-0002 by dialing the access code 642 964 895

We hope count with your participation.

HSS / MT

 
Categories

Strengthening and implementing health technology assessment and the decision-making process in the Region of the Americas

Author

Lessa, Fernanda

Caccavo, Francisco

Curtis, Stephanie

Ouimet-Rathé, Stéphanie

Lemgruber, Alexandre

Series

Rev Panam Salud Publica;41, dec. 2017

Objective. Health technology assessment (HTA) has been adopted by countries in order to improve allocative efficiency in their health systems. This study aimed to describe and analyze the HTA decision-making process in the Region of the Americas. Methods. A literature review was done to better understand the HTA situation in the Region. Also, in 2014 and 2015, individuals responsible for conducting HTA in countries of the Americas were identified and received a questionnaire on HTA and the decision-making process. Results. A total of 46 questionnaire responses were obtained, from 30 countries. The respondents were similar in terms of their institutions, main funding sources, and technology types assessed. Of the 46 respondents, 23 (50%) work for their respective ministry of health. Also, 36 (78%) undertake and/or coordinate HTA through coverage and reimbursement/pricing decisions and other HTA-related activities, while 24 (52%) use HTA for emerging technologies. While some countries in the Region have created formal HTA units, there is a weak link between the HTA process and decision-making. Most of the countries with recognized HTA institutions are members of the Health Technology Assessment Network of the Americas (RedETSA). Despite the advances in the Region overall, most countries in Central America and the Caribbean are still at the early stages of implementing HTA to support decision-making. Conclusions. Many countries in the Americas have benefited from the exchange and capacity-building opportunities within RedETSA. However, there are still many challenges to overcome in the Region in terms of the discussion and creation of HTA-related policies.

Source: http://iris.paho.org/xmlui/handle/123456789/34574

 
Categories

Belize: Ministry of Health issues first list of ‘Over the Counter’ Medications for General Use

The Ministry of Health issues the first list of Over the Counter Medications for General Use.

“Note that this is a provisional first list and the Director of Health Services will be reviewing this list continuously while making necessary modifications as we aim to keep the safety of the consumers as our primary principle.”

For more information go to http://health.gov.bz/www/publications/belize-health-information-system-unit/970-ministry-of-health-issues-first-list-of-over-the-counter-medications-for-general-use

 
Categories

INVIMA SHARES WITH PANAMA MINISTER OF HEALTH ITS SUCCESSFUL EXPERIENCE IN THE REGULATION OF MEDICINES

[Original text in spanish]

The subjects of interest on the part of the Ministry of Health of Panama (MINSA) are focused on the regulation of importation of medicines, the process of issuing the marketing authorization (medicines registry), post-marketing analysis controls, and detection of counterfeit or fraudulent medicines, among other topics will be prioritized during 2018 by Invima.

For more information go to  https://www.invima.gov.co/invima-comparte-con-minsalud-de-panam%C3%A1-su-experiencia-exitosa-regulaci%C3%B3n-de-medicamentos.html

 
Categories

Paraguay is the 128th member of the WHO Programme for International Drug Monitoring!

Paraguay have become the 128th member of the WHO Programme for International Drug Monitoring!

Currently, 129 countries are full members of the WHO Programme for International Drug Monitoring.

For more information about the Uppsala Monitoring Center go to https://www.who-umc.org/

Source: https://www.linkedin.com/feed/update/urn:li:activity:6359396252232273920

 
Categories

Peru’s Ministry of Health will strengthen regulation of generic drugs

Monday, January 15, 2018

With the objective of strengthening the supervision of generic medicines to be of quality, safe and accessible to the population, the Minister of Health, Dr. Abel Salinas Rivas, announced that the general direction of medicines of the Ministry of Health (Minsa) will become a powerful body to regulate the pharmaceutical industry.

For more information go to http://www.minsa.gob.pe/index.asp?op=51&nota=25828

 
Categories

WHO Global Benchmarking Tool (GBT) for evaluation of national regulatory systems open for comment until 28 February 2018

The Essential Medicines and Health Products (EMP) Department at WHO released a draft of the WHO Global Benchmarking Tool (GBT) version VI for comment by National Regulatory Authorities at the following link: http://www.who.int/medicines/regulation/benchmarking_tool/en/ .  The GBT is a means by which WHO evaluates medicine and vaccine regulatory systems through a comprehensive and systematic benchmarking process.

The revised draft GBT is the result of a collaborative effort between WHO headquarters and the WHO Regional Office for the Americas (PAHO/AMRO) with contributions from other Regional Offices and experts from national regulatory authorities. The tool builds on previous WHO NRA benchmarking tools and includes features of proven benefit such as computerization, categorization of indicators/sub-indicators and inclusion of fact sheets.

GBT draft version VI is open for comment until 28 February 2018. All comments should be sent to Dr Alireza Khadem, Scientist, Regulatory System Strengthening (RSS) team (khadembroojerdia@who.int) using the comments table available under the related links section. The draft tool is presented as consolidated indicators and fact sheets organized by regulatory function, together with a list of references and terminology used in the WHO GBT.